Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.98 CHF | +5.59% | +8.84% | +22.10% |
May. 03 | Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024 | CI |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG